Repository logo
 

Histone lactylation: A new epigenetic mark in the malaria parasite Plasmodium.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Epigenetic processes play important roles in the biology of the malaria parasite Plasmodium falciparum. Here, we characterised a new epigenetic mark, histone lactylation, for the first time in Plasmodium: it was found in two human malaria parasites, P. falciparum and P. knowlesi, and also in vivo in two rodent malaria models, P. yoelii and P. berghei. Histones were increasingly lactylated in response to elevated lactate levels in vitro and in vivo, making this mark uniquely well-placed to act as a metabolic sensor, since severe falciparum malaria characteristically leads to hyperlactataemia in the human host. Mass spectrometry showed that lysines on several parasite histones could be lactylated, as well as many non-histone chromatin proteins. Histone lactylation was less abundant and less inducible in P. knowlesi than P. falciparum, suggesting that P. falciparum may have evolved particular epigenetic responses to this characteristic feature of its pathology. Finally, in the rodent model P. yoelii, hyperlactataemia correlated with parasite transcriptomic programmes that suggested metabolic 'dormancy'.

Description

Acknowledgements: We acknowledge the Cambridge Centre for Proteomics for mass spectrometry; the staff of Imperial College Central Biomedical Services for support with animal experiments; Till Voss (Swiss TPH) for the HP1-HA parasite line; and Rachana Ramarao and Anders Jensen for early work on this project.


Funder: Isaac Newton Trust; funder-id: http://dx.doi.org/10.13039/501100004815


Funder: Alborada Fund


Funder: Cambridge JRG Scheme


Funder: GHIT

Journal Title

PLoS Genet

Conference Name

Journal ISSN

1553-7390
1553-7404

Volume Title

21

Publisher

Public Library of Science (PLoS)

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Wellcome Trust (225171/Z/22/Z)
MRC (MR/W025701/1)
Medical Research Council (MR/N00227X/1)